At the outset, let me emphasize my appreciation for your informative posts. I share your enthusiasm for all the meritorious projects that PSTI has in the pipeline.
However, I've never been a big fan of blaming a "controller" or "price manipulation" for a depressed pps. Why can't we simply state that PSTI is still a relatively unknown company with a modest volume of trading? The fact that the average daily volume is only 500,000 shares is testament. to that fact. Most of the major analysts aren't even providing coverage on the stock. Now, you and I are optimistic that that will soon change. A big licensing deal would surely get us increased positive exposure
Hey allo, the fact that we keep blaming the controller for the depressed pps doesn't really make me feel better. If he's trying to keep the price down now, what's to stop him from trying to control any rally we get after PSTI releases good news?
I honestly have no idea what they'll do. You are right that their DCF has been abominable. I know that they have been committed to the distribution, but whether they can continue the same level is a fair question.
The market must be expecting a distribution cut. If the distribution is held steady, then CLMT is a 11.5% yield. 2015 should be a good year, but the market is never known for patience.
Yeah, I know in Straumins' case a sale of 15,000 shares is no biggie. Still, it's the first insider selling i've ever seen since I bought CLMT.
Agreed, coachzack. With the Indonesian situation cleared up, we should be back in the high 30s by the end of spring.
Understand, i'm not at all upset with PSTI. Mgmt. has been making all the right moves. I'm just frustrated that the market hasn't yet seen what a gold mine we have.
Well, voova, I am learning that what i think is a big event is different than what the market thinks. When we released the good news on January 22 regarding treatments for muscle injury, I thought we'd immediately zoom north of $5.
was that I really think the FDA approval was a non-event. When I heard that PSTI was trading in the 4.30s pre-market, I figured something big had happened. I'm glad that we broke out of our $4 to $4.15 price range, and we still haven't gotten news of a big pharma deal, or orphan approval of the pre-eclampsia therapy. That kind of news should get us up to $6.
I'd like to see us soon get back to the 4.60s, which is where we were about the time of the Jan 22 announcement. I don't understand why the pps declined afterwards.
Allo, don't let the idiots rattle you. They attack you because they know you're providing good information. Keep up the good work!